For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Exosome Diagnostics, Inc.

USPTO Granted Patents = 20

CIPO Patents = 3

EPO Patents = 20

Trademarks = 4

Forward Citations = 40

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Johan Karl Olov Skog (16 out of 24 patents)

Mikkel Noerholm (7 out of 10 patents)

Leileata M Russo (6 out of 7 patents)

4. Robert Kitchen (6 out of 6 patents)

5. Vasisht Tadigotla (4 out of 4 patents)

6. Daniel Enderle (4 out of 5 patents)

7. Wei Yu (4 out of 18 patents)

8. Johan Skog (4 out of 5 patents)

9. Wayne Comper (3 out of 3 patents)

10. Dalin Chan (3 out of 3 patents)

11. James Hurley (3 out of 3 patents)

12. Sudipto Chakrabortty (2 out of 2 patents)

13. Michael Valentino (2 out of 2 patents)

14. Dominik Grimm (2 out of 2 patents)

15. Aparna Ramachandran (2 out of 2 patents)

20 patents: Sort by Forward Citations

1. 12493029 - Compositions, methods, and kits for the isolation of extracellular vesicles (2025-12-09),

2. 12378608 - Methods for developing urine biomarkers and for detecting bladder cancer (2025-08-05),

3. 12312582 - Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom (2025-05-27),

4. 12258587 - Compositions and methods for internal controls of microvesicle isolations (2025-03-25),

5. 12018334 - Controls for nucleic acid assays (2024-06-25),

6. 11899024 - Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles (2024-02-13),

7. 11891664 - Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers (2024-02-06),

8. 11457899 - Apparatuses, methods, and systems for sample collection and dispersion (2022-10-04),

9. 11427864 - Methods and compositions to detect mutations in plasma using exosomal RNA and cell free DNA from non-small cell lung cancer patients (2022-08-30),

10. 11407991 - Nucleic acid extraction from heterogeneous biological materials (2022-08-09),

11. 11396676 - Sequencing and analysis of exosome associated nucleic acids (2022-07-26),

12. 11345957 - Methods of treating glioblastoma in a subject informed by exosomal RNA signatures (2022-05-31),

13. 11268085 - Methods for isolating microvesicles and extracting nucleic acids from biological samples (2022-03-08),

14. 11214833 - Profiling microvesicle nucleic acids and uses thereof as signatures in diagnosis of renal transplant rejection (2022-01-04),

15. 11136627 - Controls for nucleic acid assays (2021-10-05),

Company Overview

Exosome Diagnostics, Inc., based in Waltham, MA, specializes in the development of innovative diagnostic solutions utilizing exosome technology. The company focuses on advancing precision medicine through non-invasive liquid biopsy tests that provide insights into various diseases, including cancer. By harnessing the potential of exosomes, which are small vesicles released by cells, Exosome Diagnostics aims to enhance disease detection and monitoring, ultimately improving patient outcomes and facilitating personalized treatment strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

20 Patents

#71 in Waltham, MA

#985 in Massachusetts

#16,395 in US

#31,264 in the World

Waltham, MA, United States of America

Exosome Diagnostics, Inc.

Forward Citations = 40

33 inventors:

Johan Karl Olov Skog (16 out of 24 patents)

Mikkel Noerholm (7 out of 10 patents)

Leileata M Russo (6 out of 7 patents)

4. Robert Kitchen (6 out of 6 patents)

5. Vasisht Tadigotla (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Exosome Diagnostics, Inc.. Retrieved from https://idiyas.com/company/exosome-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…